108 related articles for article (PubMed ID: 12561447)
1. [Research advances on bladder cancer associated genes].
Zhang R; Zhang JJ; He ZG; Cheng SJ; Gao YN
Ai Zheng; 2003 Jan; 22(1):104-7. PubMed ID: 12561447
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetics and biochemical mechanisms in bladder cancer. Oncogenes, tumor suppressor genes, and growth factors.
Sidransky D; Messing E
Urol Clin North Am; 1992 Nov; 19(4):629-39. PubMed ID: 1441021
[TBL] [Abstract][Full Text] [Related]
3. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.
Zaharieva BM; Simon R; Diener PA; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Hering F; Schönenberger A; Flury R; Jäger P; Fehr JL; Mihatsch MJ; Gasser T; Sauter G; Toncheva DI
J Pathol; 2003 Dec; 201(4):603-8. PubMed ID: 14648664
[TBL] [Abstract][Full Text] [Related]
4. Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C
Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations in urothelial bladder carcinoma: an updated review.
Mhawech-Fauceglia P; Cheney RT; Schwaller J
Cancer; 2006 Mar; 106(6):1205-16. PubMed ID: 16470587
[TBL] [Abstract][Full Text] [Related]
6. [Progress of research on tumor suppressor genes].
Kuzumaki N
Hokkaido Igaku Zasshi; 1996 Mar; 71(2):133-7. PubMed ID: 8641669
[TBL] [Abstract][Full Text] [Related]
7. Molecular biology of bladder cancer.
Borland RN; Brendler CB; Isaacs WB
Hematol Oncol Clin North Am; 1992 Feb; 6(1):31-9. PubMed ID: 1556051
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
[TBL] [Abstract][Full Text] [Related]
9. Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitional cell carcinoma of the bladder.
Knowles MA; Habuchi T; Kennedy W; Cuthbert-Heavens D
Cancer Res; 2003 Nov; 63(22):7652-6. PubMed ID: 14633685
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated genes can affect somatic intrachromosomal recombination early in carcinogenesis.
Hooker AM; Morley AA; Tilley WD; Sykes PJ
Mutat Res; 2004 Jun; 550(1-2):1-10. PubMed ID: 15135636
[TBL] [Abstract][Full Text] [Related]
11. Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients.
Friedrich MG; Weisenberger DJ; Cheng JC; Chandrasoma S; Siegmund KD; Gonzalgo ML; Toma MI; Huland H; Yoo C; Tsai YC; Nichols PW; Bochner BH; Jones PA; Liang G
Clin Cancer Res; 2004 Nov; 10(22):7457-65. PubMed ID: 15569975
[TBL] [Abstract][Full Text] [Related]
12. Controlling apoptosis: implications for carcinogenesis?
Clarke AR
Symp Soc Exp Biol; 2000; 52():265-75. PubMed ID: 12090014
[No Abstract] [Full Text] [Related]
13. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.
Shen M; Hung RJ; Brennan P; Malaveille C; Donato F; Placidi D; Carta A; Hautefeuille A; Boffetta P; Porru S
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1234-40. PubMed ID: 14652287
[TBL] [Abstract][Full Text] [Related]
14. Multiple epithelial and nonepithelial tumors in hereditary nonpolyposis colorectal cancer: characterization of germline and somatic mutations of the MSH2 gene and heterogeneity of replication error phenotypes.
Huang RL; Chao CF; Ding DC; Yu CP; Chang CC; Lai HC; Yu MH; Liu HS; Chu TY
Cancer Genet Cytogenet; 2004 Sep; 153(2):108-14. PubMed ID: 15350299
[TBL] [Abstract][Full Text] [Related]
15. [Oncogene and tumor suppressor gene].
Watanabe N
Rinsho Byori; 2002 Nov; Suppl 123():131-6. PubMed ID: 12652800
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetics of bladder cancer: targets for diagnosis and therapy.
Baffa R; Letko J; McClung C; LeNoir J; Vecchione A; Gomella LG
J Exp Clin Cancer Res; 2006 Jun; 25(2):145-60. PubMed ID: 16918124
[TBL] [Abstract][Full Text] [Related]
17. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer.
Kawamoto K; Enokida H; Gotanda T; Kubo H; Nishiyama K; Kawahara M; Nakagawa M
Biochem Biophys Res Commun; 2006 Jan; 339(3):790-6. PubMed ID: 16316628
[TBL] [Abstract][Full Text] [Related]
18. A molecular genetic model of human bladder carcinogenesis.
Reznikoff CA; Kao C; Messing EM; Newton M; Swaminathan S
Semin Cancer Biol; 1993 Jun; 4(3):143-52. PubMed ID: 8318690
[TBL] [Abstract][Full Text] [Related]
19. Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer.
Knowles MA; Aveyard JS; Taylor CF; Harnden P; Bass S
Cancer Lett; 2005 Jul; 225(1):121-30. PubMed ID: 15922864
[TBL] [Abstract][Full Text] [Related]
20. [Expression of dominant oncogenes and tumor suppressor genes in bladder carcinoma].
Sánchez-Chapado M; Angulo Cuesta J
Arch Esp Urol; 1995; 48(1):1-12. PubMed ID: 7733682
[No Abstract] [Full Text] [Related]
[Next] [New Search]
